StonvexLoading…
StonvexStonvexStonvexCore line items from EMR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 | Annual 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $18.02B | $4.55B | $4.43B | $4.17B |
Operating Income | $2.93B | Not available | Not available | Not available |
Net Income | $2.29B | $586.00M | $485.00M | $585.00M |
EPS (Diluted) | $4.04 | $1.04 | $0.86 | $1.02 |
Total Assets | $41.96B | Not available | Not available | Not available |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.54B | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $2.67B | Not available | Not available | Not available |
Shares Outstanding | 562.80M | Not available | Not available | Not available |